中华皮肤科杂志 ›› 2025, Vol. 58 ›› Issue (6): 567-572.doi: 10.35541/cjd.20240419
梁高澎 杨显杰 陈奇权 宋志强
收稿日期:2024-08-07
修回日期:2025-04-08
发布日期:2025-06-03
通讯作者:
宋志强
E-mail:drsongzq@tmmu.edu.cn
基金资助:Liang Gaopeng, Yang Xianjie, Chen Qiquan, Song Zhiqiang
Received:2024-08-07
Revised:2025-04-08
Published:2025-06-03
Contact:
Song Zhiqiang
E-mail:drsongzq@tmmu.edu.cn
Supported by:摘要： 【摘要】 慢性荨麻疹（CU）是皮肤科门诊最常见的疾病之一，以反复发作的风团、瘙痒为主要表现。其常与其他疾病共存，常见的共病包括自身免疫性疾病、感染性疾病、过敏性疾病、精神疾病、代谢综合征、恶性肿瘤以及内分泌系统相关疾病等。目前国内外指南尚未对CU共病的筛查提供具体建议，本文综述CU常见的共病，以期为临床诊疗提供参考。
梁高澎 杨显杰 陈奇权 宋志强. 慢性荨麻疹共病的研究现状及进展[J]. 中华皮肤科杂志, 2025,58(6):567-572. doi:10.35541/cjd.20240419
Liang Gaopeng, Yang Xianjie, Chen Qiquan, Song Zhiqiang. Comorbidities of chronic urticaria[J]. Chinese Journal of Dermatology, 2025, 58(6): 567-572.doi:10.35541/cjd.20240419
| ［1］ | Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta⁃analysis［J］. Allergy, 2020,75（2）:423⁃432. doi: 10.1111/all.14037. |
| ［2］ | Maurer M, Abuzakouk M, Bérard F, et al. The burden of chronic spontaneous urticaria is substantial: real⁃world evidence from ASSURE⁃CSU［J］. Allergy, 2017,72（12）:2005⁃2016. doi: 10. 1111/all.13209. |
| ［3］ | Staubach P, Mann C, Peveling⁃Oberhag A, et al. Epidemiology of urticaria in German children［J］. J Dtsch Dermatol Ges, 2021,19（7）:1013⁃1019. doi: 10.1111/ddg.14485. |
| ［4］ | Papapostolou N, Xepapadaki P, Katoulis A, et al. Comorbidities of chronic urticaria: a glimpse into a complex relationship［J］. Front Allergy, 2022,3:1008145. doi: 10.3389/falgy.2022.1008145. |
| ［5］ | Deng L, Yao Y, Lu Z, et al. Causal associations between chronic spontaneous urticaria and thyroid function indicators on different ethnic groups: a bidirectional two⁃sample mendelian randomization analysis［J］. Allergy, 2024. doi: 10.1111/all.16400. |
| ［6］ | Kolkhir P, Bieber K, Hawro T, et al. Mortality in adult patients with chronic spontaneous urticaria: a real⁃world cohort study［J］. J Allergy Clin Immunol, 2025,155（4）:1290⁃1298. doi: 10.1016/j.jaci.2024.11.036. |
| ［7］ | Barzilai A, Baum A, Ben⁃Shoshan M, et al. Epidemiological and clinical characteristics of adult and pediatric patients with chronic spontaneous urticaria［J］. J Clin Med, 2023,12（23）:7482. doi: 10.3390/jcm12237482. |
| ［8］ | Conrad N, Misra S, Verbakel JY, et al. Incidence, prevalence, and co⁃occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population⁃based cohort study of 22 million individuals in the UK［J］. Lancet, 2023,401（10391）:1878⁃1890. doi: 10.1016/S0140⁃6736（23）00457⁃9. |
| ［9］ | Le M, Zhang L, Gabrielli S, et al. Increased prevalence of autoimmune diseases in children with chronic spontaneous urticaria［J］. Pediatr Allergy Immunol, 2022,33（2）:e13736. doi: 10.1111/pai.13736. |
| ［10］ | Kolkhir P, Altrichter S, Asero R, et al. Autoimmune diseases are linked to typeⅡb autoimmune chronic spontaneous urticaria［J］. Allergy Asthma Immunol Res, 2021,13（4）:545⁃559. doi: 10. 4168/aair.2021.13.4.545. |
| ［11］ | Magen E, Zueva E, Mishal J, et al. The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria［J］. Allergy Asthma Proc, 2016,37（5）:394⁃399. doi: 10.2500/aap.2016.37.3971. |
| ［12］ | Tienforti D, Di Giulio F, Spagnolo L, et al. Chronic urticaria and thyroid autoimmunity: a meta⁃analysis of case⁃control studies［J］. J Endocrinol Invest, 2022,45（7）:1317⁃1326. doi: 10.1007/s40618⁃022⁃01761⁃2. |
| ［13］ | Gonzalez⁃Diaz SN, Sanchez⁃Borges M, Rangel⁃Gonzalez DM, et al. Chronic urticaria and thyroid pathology［J］. World Allergy Organ J, 2020,13（3）:100101. doi: 10.1016/j.waojou.2020.100101. |
| ［14］ | Selvendran SS, Aggarwal N. Chronic urticaria and thyroid autoimmunity: a perplexing association［J］. Oxf Med Case Reports, 2018,2018（2）:omx099. doi: 10.1093/omcr/omx099. |
| ［15］ | Zysk W, Trzeciak M. Characterization of chronic urticaria and associated conditions ⁃ a web⁃based survey［J］. Dermatol Pract Concept, 2023,13（1）:e2023056. doi: 10.5826/dpc.1301a56. |
| ［16］ | Xiao M, Zhang X, Guo A, et al. A retrospective cohort study on the comorbidity in 19,264 Chinese patients of different ages with urticaria［J］. Acta Derm Venereol, 2024,104:adv24050. doi: 10.2340/actadv.v104.24050. |
| ［17］ | Guo Y, Li HM, Zhu WQ, et al. Role of Helicobacter pylori eradication in chronic spontaneous urticaria: a propensity score matching analysis［J］. Clin Cosmet Investig Dermatol, 2021,14:129⁃136. doi: 10.2147/CCID.S293737. |
| ［18］ | Sánchez Caraballo A, Guzmán Y, Sánchez J, et al. Potential contribution of Helicobacter pylori proteins in the pathogenesis of type 1 gastric neuroendocrine tumor and urticaria. In silico approach［J］. PLoS One, 2023,18（4）:e0281485. doi: 10.1371/journal.pone.0281485. |
| ［19］ | Gu H, Li L, Gu M, et al. Association between Helicobacter pylori infection and chronic urticaria: a meta⁃analysis［J］. Gastroenterol Res Pract, 2015,2015:486974. doi: 10.1155/2015/486974. |
| ［20］ | Watanabe J, Shimamoto J, Kotani K. The effects of antibiotics for Helicobacter pylori eradication or dapsone on chronic spontaneous urticaria: a systematic review and meta⁃analysis［J］. Antibiotics （Basel）, 2021,10（2）:156. doi: 10.3390/antibiotics 10020156. |
| ［21］ | He L, Yi W, Huang X, et al. Chronic urticaria: advances in understanding of the disease and clinical management［J］. Clin Rev Allergy Immunol, 2021,61（3）:424⁃448. doi: 10.1007/s12016⁃021⁃08886⁃x. |
| ［22］ | Navarro⁃Triviño FJ, Ruiz⁃Villaverde R. Changes in liver viral load in hepatitis B virus infection during treatment of chronic urticaria with omalizumab: is there a pathophysiologic relationship between the 2 diagnostic entities?［J］. Actas Dermosifiliogr, 2022,113 Suppl 1:S20⁃S22. doi: 10.1016/j.ad.2021.09.001. |
| ［23］ | Kanazawa K, Yaoita H, Tsuda F, et al. Hepatitis C virus infection in patients with urticaria［J］. J Am Acad Dermatol, 1996,35（2 Pt 1）:195⁃198. doi: 10.1016/s0190⁃9622（96）90322⁃9. |
| ［24］ | Tiotiu A, Jaussaud R. Successful treatment with omalizumab for cold urticaria in a patient with chronic hepatitis C virus infection［J］. Eur J Dermatol, 2022,32（5）:640⁃641. doi: 10.1684/ejd. 2022.4324. |
| ［25］ | Brar AK, Grace J. Urticaria and HIV infection: a case report［J］. Cureus, 2022,14（9）:e29662. doi: 10.7759/cureus.29662. |
| ［26］ | Iemoli E, Niero F, Borgonovo L, et al. Successful omalizumab treatment in HIV positive patient with chronic spontaneous urticaria: a case report［J］. Eur Ann Allergy Clin Immunol, 2017,49（2）:88⁃91. |
| ［27］ | 中华医学会皮肤性病学分会荨麻疹研究中心. 抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识［J］. 中华皮肤科杂志, 2021,54（12）:1057⁃1062. doi: 10.35541/cjd.20210568. |
| ［28］ | Chiu HY, Muo CH, Sung FC. Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population⁃based study［J］. Int J Dermatol, 2018,57（7）:822⁃829. doi: 10.1111/ijd.14000. |
| ［29］ | Pourali SP, Kohn AH, Jones ME, et al. Chronic spontaneous urticaria: a 16⁃year analysis of pediatric patient demographics, treatment patterns, and comorbidities［J］. Dermatol Online J, 2021,27（8）doi: 10.5070/D327854723. |
| ［30］ | 苏畅, 隋秀丽, 刘瑞玲, 等. 奥马珠单抗治疗慢性自发性荨麻疹伴有其他过敏性疾病患者74例临床分析［J］. 中华皮肤科杂志, 2023,56（6）:512⁃517. doi: 10.35541/cjd.20220931. |
| ［31］ | 严彩蓉, 亓玉青, 隋秀丽, 等. 奥马珠单抗治疗儿童和老年慢性自发性荨麻疹患者的短期疗效及安全性［J］. 中国皮肤性病学杂志, 2024,38（1）:40⁃44. doi: 10.13735/j.cjdv.1001⁃7089.202304062. |
| ［32］ | Jo YH, Yoo HW, Kim SH, et al. Clinical characteristics and treatment response of chronic spontaneous urticaria according to age: a single⁃center Korean study［J］. Asian Pac J Allergy Immunol, 2022,40（4）:374⁃378. doi: 10.12932/AP⁃050719⁃0594. |
| ［33］ | Galletta F, Caminiti L, Lugarà C, et al. Long⁃term safety of omalizumab in children with asthma and/or chronic spontaneous urticaria: a 4⁃year prospective study in real life［J］. J Pers Med, 2023,13（7）:1068. doi: 10.3390/jpm13071068. |
| ［34］ | Konstantinou GN, Konstantinou GN. Psychological stress and chronic urticaria: a neuro⁃immuno⁃cutaneous crosstalk. a systematic review of the existing evidence［J］. Clin Ther, 2020,42（5）:771⁃782. doi: 10.1016/j.clinthera.2020.03.010. |
| ［35］ | Ghazanfar MN, Kibsgaard L, Thomsen SF, et al. Risk of comorbidities in patients diagnosed with chronic urticaria: a nationwide registry⁃study［J］. World Allergy Organ J, 2020,13（1）:100097. doi: 10.1016/j.waojou.2019.100097. |
| ［36］ | Weller K, Maurer M, Bauer A, et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany［J］. J Eur Acad Dermatol Venereol, 2022,36（1）:91⁃99. doi: 10.1111/jdv.17724. |
| ［37］ | Elçin A, Ayla G, Tuba Saadet Deveci B, et al. Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab［J］. Allergol Immunopathol （Madr）, 2024,52（3）:1⁃7. doi: 10.15586/aei.v52i3.1015. |
| ［38］ | Beyaz S, Demir S, Oztop N, et al. Psychological burden of COVID⁃19 on mild and moderate chronic spontaneous urticaria［J］. Allergy Asthma Proc, 2021,42（4）:e107⁃e115. doi: 10.2500/aap. 2021.42.210026. |
| ［39］ | Tzur Bitan D, Berzin D, Cohen A. The association of chronic spontaneous urticaria （CSU） with anxiety and depression: a nationwide cohort study［J］. Arch Dermatol Res, 2021,313（1）:33⁃39. doi: 10.1007/s00403⁃020⁃02064⁃3. |
| ［40］ | Choi GS, Nam YH, Park CS, et al. Anxiety, depression, and stress in Korean patients with chronic urticaria［J］. Korean J Intern Med, 2020,35（6）:1507⁃1516. doi: 10.3904/kjim.2019.320. |
| ［41］ | Stadler PC, Marsela E, Kämmerer T, et al. Impact of allergic reactions and urticaria on mental health and quality of life［J］. Allergol Immunopathol （Madr）, 2022,50（2）:124⁃130. doi: 10. 15586/aei.v50i2.525. |
| ［42］ | Gupta MA, Gupta AK. Chronic idiopathic urticaria and post⁃traumatic stress disorder （PTSD）: an under⁃recognized comorbidity［J］. Clin Dermatol, 2012,30（3）:351⁃354. doi: 10.1016/j.clindermatol.2012.01.012. |
| ［43］ | Özkaya E, Babuna Kobaner G, Yılmaz Z, et al. Doxepin in difficult⁃to⁃treat chronic urticaria: a retrospective, cross⁃sectional study from Turkey［J］. Dermatol Ther, 2019,32（4）:e12993. doi: 10.1111/dth.12993. |
| ［44］ | Tan MG, Bailey A, Dorus B, et al. Clinical impacts of omalizumab on the psychiatric comorbidities of chronic spontaneous urticaria: a systematic review and meta⁃analysis［J］. J Drugs Dermatol, 2024,23（4）:e116⁃e117. doi: 10.36849/JDD.7919. |
| ［45］ | Gupta P, Bishnoi A, Bakshi S, et al. Chronic spontaneous urticaria and metabolic syndrome: a relationship conundrum［J］. Arch Dermatol Res, 2023,315（8）:2445⁃2448. doi: 10.1007/s00403⁃023⁃02636⁃z. |
| ［46］ | Reddy M, Kolalapudi SA, Praveen S, et al. Clinical and laboratory parameters of metabolic syndrome in chronic spontaneous urticaria: a cross⁃sectional study［J］. Indian Dermatol Online J, 2025,16（1）:105⁃109. doi: 10.4103/idoj.idoj_945_24. |
| ［47］ | Kaşıkçı EE, Özışık M, Bayrak Değirmenci P. Evaluation of antihistamine⁃refractory chronic urticaria patients who used biological agent treatment in terms of cardiovascular risk［J］. Postepy Dermatol Alergol, 2024,41（6）:610⁃616. doi: 10.5114/ada.2024.145572. |
| ［48］ | Wagner N, Berking C. Recognition and management of relevant comorbidities in chronic spontaneous urticaria［J］. Dermatologie （Heidelb）, 2024,75（4）:289⁃294. doi: 10.1007/s00105⁃024⁃05311⁃0. |
| ［49］ | Ratliff JC, Barber JA, Palmese LB, et al. Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey［J］. Obesity （Silver Spring）, 2010,18（12）:2398⁃2400. doi: 10.1038/oby. 2010.176. |
| ［50］ | Martina E, Damiani G, Grieco T, et al. It is never too late to treat chronic spontaneous urticaria with omalizumab: real⁃life data from a multicenter observational study focusing on elderly patients［J］. Dermatol Ther, 2021,34（2）:e14841. doi: 10.1111/dth.14841. |
| ［51］ | Falay Gur T, Savas Erdogan S, Erdemir VA, et al. Effect of omalizumab use on glucose homeostasis in non⁃diabetic patients with chronic urticaria［J］. Cutan Ocul Toxicol, 2020,39（4）:348⁃353. doi: 10.1080/15569527.2020.1818769. |
| ［52］ | Sørensen S, Farkas DK, Vestergaard C, et al. Urticaria and the risk of cancer: a Danish population⁃based cohort study［J］. Br J Dermatol, 2024,191（5）:706⁃712. doi: 10.1093/bjd/ljae264. |
| ［53］ | Napolitano M, Patruno C. Chronic urticaria can be caused by cancer and resolves with its cure［J］. Allergy, 2018,73（8）:1750⁃1751. doi: 10.1111/all.13477. |
| ［54］ | Sutton KM, Wiggins M, Zaragoza R, et al. Chronic spontaneous urticaria as the presenting feature in a paediatric case of chronic myeloid leukaemia［J］. Pediatr Blood Cancer, 2024,71（3）:e30846. doi: 10.1002/pbc.30846. |
| ［55］ | Miletić AI, Habek D, Medić F, et al. Ovarian yolk sac tumor in a premenarchal girl［J］. Wien Med Wochenschr, 2023,173（3⁃4）:70⁃73. doi: 10.1007/s10354⁃022⁃00996⁃1. |
| ［56］ | Bauer AT, Gorzelanny C, Gebhardt C, et al. Interplay between coagulation and inflammation in cancer: limitations and therapeutic opportunities［J］. Cancer Treat Rev, 2022,102:102322. doi: 10. 1016/j.ctrv.2021.102322. |
| ［57］ | Verdoodt F, Pottegård A, Dehlendorff C, et al. Antihistamine use and risk of ovarian cancer: a population⁃based case⁃control study［J］. Maturitas, 2019,120:47⁃52. doi: 10.1016/j.maturitas.2018. 11.014. |
| ［58］ | Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H（1）⁃antihistamines desloratadine and loratadine［J］. Transl Oncol, 2021,14（4）:101029. doi: 10.1016/j.tranon.2021.101029. |
| ［59］ | Liu P, Kroemer G, Kepp O. Histamine antagonists promote cancer immunosurveillance［J］. Oncoimmunology, 2023,12（1）:2242211. doi: 10.1080/2162402X.2023.2242211. |
| ［60］ | Cully M. Anti⁃histamines boost immunotherapy［J］. Nat Rev Drug Discov, 2022,21（1）:17. doi: 10.1038/d41573⁃021⁃00204⁃6. |
| ［61］ | Hayama K, Fujita H, Asai⁃Sato M, et al. Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer［J］. Eur J Dermatol, 2021,31（1）:100⁃101. doi: 10.1684/ejd.2020.3959. |
| ［62］ | Navarro⁃Triviño FJ, Mérida⁃Fernández C, Linares⁃Gonzalez L, et al. Is omalizumab safe and effective in oncological patients?［J］. Dermatol Ther, 2019,32（6）:e13115. doi: 10.1111/dth.13115. |
| ［63］ | Staubach P, Bilo B, Fluhr JW, et al. UCOMB⁃real life data: treatment strategies for chronic urticaria patients with comorbidities［J］. J Dermatolog Treat, 2024,35（1）:2329784. doi: 10.1080/09546634.2024.2329784. |
| ［64］ | Ornek SA, Suroji Alkilinc A, Kızıltac U, et al. Effect of puberty, menstruation, pregnancy, lactation, and menopause on chronic urticaria activity［J］. J Cutan Med Surg, 2023,27（5）:466⁃471. doi: 10.1177/12034754231191472. |
| ［65］ | Zhang H, Wang M, Zhao X, et al. Role of stress in skin diseases: a neuroendocrine⁃immune interaction view［J］. Brain Behav Immun, 2024,116:286⁃302. doi: 10.1016/j.bbi.2023.12.005. |
| ［66］ | Kocatürk E, Al⁃Ahmad M, Krause K, et al. Effects of pregnancy on chronic urticaria: results of the PREG⁃CU UCARE study［J］. Allergy, 2021,76（10）:3133⁃3144. doi: 10.1111/all.14950. |
| [1] | 唐汇洋 杨芷 样希 姚正秋 陈邦涛 郝飞. 氧化三甲胺参与慢性自发性荨麻疹发病的机制研究[J]. 中华皮肤科杂志, 2025, 58(6): 515-522. |
| [2] | 肖萌 赵美茹 张新美 张俊艳 亓玉青 王惠平. 慢性自发性荨麻疹患者疾病负担的单中心回顾性分析[J]. 中华皮肤科杂志, 2025, 58(6): 530-535. |
| [3] | 梁碧华 陈紫嫣 李华平 邹荟 林天一 李晓峰 张珞喻 李圣信 欧珊珊 陈教全 李润祥 朱慧兰. Olink靶向蛋白质组学技术分析慢性自发性荨麻疹患者抗组胺药治疗抵抗相关血清炎症因子[J]. 中华皮肤科杂志, 2025, 58(6): 523-529. |
| [4] | 邱里 肖汀. 布鲁顿酪氨酸激酶抑制剂在慢性自发性荨麻疹治疗中的进展[J]. 中华皮肤科杂志, 2025, 58(6): 563-567. |
| [5] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会. 中国难治性慢性自发性荨麻疹诊治指南（2025版）[J]. 中华皮肤科杂志, 2025, 58(6): 485-496. |
| [6] | 李家明 王鹏 康晓静. 皮肤恶性肿瘤铁死亡机制与相关干预措施研究进展[J]. 中华皮肤科杂志, 2025, 0(3): 20240125-e20240125. |
| [7] | 李秀珍 徐秀莲. 白细胞介素23抑制剂治疗对银屑病共病的影响[J]. 中华皮肤科杂志, 2025, 58(3): 268-272. |
| [8] | 高俊 周群. 武汉市1952—2023年麻风流行特征及趋势分析[J]. 中华皮肤科杂志, 2025, 0(2): 20240444-e20240444. |
| [9] | 岳淑珍 树叶 罗鸯鸯 李珂瑶 张圆圆 汤建萍 韦祝. 奥马珠单抗治疗儿童慢性荨麻疹的疗效和安全性回顾研究[J]. 中华皮肤科杂志, 2024, 57(4): 354-358. |
| [10] | 田静 邓思思 宋志强. 特应性与非特应性结节性痒疹患者临床特征比较[J]. 中华皮肤科杂志, 2024, 57(4): 331-337. |
| [11] | 陈玉沙 汪盛. 遗传性光敏感性皮肤病[J]. 中华皮肤科杂志, 2024, 57(3): 279-282. |
| [12] | 许焯红 周栩悦 胡煜 顾恒. 慢性自发性荨麻疹发病过程中肥大细胞作用及其靶向治疗进展[J]. 中华皮肤科杂志, 2024, 0(3): 20240291-e20240291. |
| [13] | 蒋献 宋德宇. [开放获取] 从心身医学视角认识玫瑰痤疮[J]. 中华皮肤科杂志, 2024, 57(2): 123-126. |
| [14] | 赵苗苗 于佩瑶 杨海茜 于英瑶 马丽 牟文佳 尚元元. 奥马珠单抗治疗慢性自发性荨麻疹的疗效、安全性和影响因素：前瞻性单中心研究[J]. 中华皮肤科杂志, 2024, 57(12): 1091-1098. |
| [15] | 谢欣然 张璐 杜丹 李晓雪 李焰梅 蒋献. 特应性皮炎共病的研究进展[J]. 中华皮肤科杂志, 2024, 57(11): 1058-1063. |
|
